Golden Royal Development Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223031626 Filed on September 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $190.00 $5.00 $12.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $190.00 $5.00 $12.00
YoY Change -58.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $84.80K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $258.2K $248.4K $181.2K
YoY Change 30.61% 37.07%
SHAREHOLDERS EQUITY
Retained Earnings -$288.3K -$278.7K -$229.3K
YoY Change 26.45% 21.53% -250.45%
Common Stock $78.00 $78.00 $78.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$258.0K -$248.4K -$181.2K
YoY Change
Total Liabilities & Shareholders Equity $190.00 $5.00 $12.00
YoY Change -58.33%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001761534
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Cash
Cash
usd
CY2022Q3 us-gaap Assets
Assets
usd
CY2023Q2 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-56017
dei Entity Registrant Name
EntityRegistrantName
GOLDEN ROYAL DEVELOPMENT INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4563277
dei Entity Address Address Line1
EntityAddressAddressLine1
80 Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 415
dei Entity Address City Or Town
EntityAddressCityOrTown
West Orange
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07052
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
320-4394
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7841550 shares
CY2023Q2 us-gaap Cash
Cash
5 usd
CY2023Q2 us-gaap Assets
Assets
5 usd
CY2022Q3 us-gaap Bank Overdrafts
BankOverdrafts
248 usd
CY2023Q2 us-gaap Liabilities
Liabilities
248378 usd
CY2022Q3 us-gaap Liabilities
Liabilities
197666 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
78 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
78 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30222 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30222 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-278674 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227967 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-248373 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-197666 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
14423 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
3070 usd
us-gaap Professional Fees
ProfessionalFees
40549 usd
us-gaap Professional Fees
ProfessionalFees
29883 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1692 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6909 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10158 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16978 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
16115 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
9979 usd
us-gaap Operating Expenses
OperatingExpenses
50707 usd
us-gaap Operating Expenses
OperatingExpenses
46861 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16115 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9979 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50707 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46861 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16115 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9979 usd
us-gaap Net Income Loss
NetIncomeLoss
-50707 usd
us-gaap Net Income Loss
NetIncomeLoss
-46861 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7841550 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7841550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7841550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7841550 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-197666 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8672 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-206338 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25920 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-232258 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16115 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-248373 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-134326 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-14160 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-148486 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22722 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-171208 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-171208 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9979 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9979 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-181187 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-181187 usd
us-gaap Net Income Loss
NetIncomeLoss
-50707 usd
us-gaap Net Income Loss
NetIncomeLoss
-46861 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
300 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
900 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23351 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29046 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27056 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16915 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-248 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35602 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17529 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
8293 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
699 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27061 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16830 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-85 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
8293 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
699 usd
CY2018Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
100 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1200 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
900 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zsxd7ybrzwF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">(B) <span id="xdx_866_zfDToAmT1F9j">Use of Estimates</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1100 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2050 usd
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2023Q1 us-gaap Area Of Land
AreaOfLand
80 acre
CY2023Q1 us-gaap Area Of Land
AreaOfLand
80 acre
us-gaap Asset Impairment Charges
AssetImpairmentCharges
300 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-50707 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27056 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-278674 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-248373 usd
CY2023Q2 GRDV Working Capital
WorkingCapital
-248378 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5 usd

Files In Submission

Name View Source Status
0001493152-23-031626-index-headers.html Edgar Link pending
0001493152-23-031626-index.html Edgar Link pending
0001493152-23-031626.txt Edgar Link pending
0001493152-23-031626-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
grdv-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
grdv-20230630_def.xml Edgar Link unprocessable
grdv-20230630_lab.xml Edgar Link unprocessable
grdv-20230630_pre.xml Edgar Link unprocessable
grdv-20230630_cal.xml Edgar Link unprocessable